Cost-effectiveness of adult circumdsion in a resource-rich setting for HIV prevention among men who have sex with men

Journal of Infectious Diseases

Volumn 200, Issue 12, 2009, Pages 1803-1812

  Anderson, Jonathan ^a   Wilson, David ^a   Templeton, David J ^a,b   Grulich, Andrew ^a   Carter, Robert ^c   Kaldor, John ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; CIRCUMCISION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MATHEMATICAL MODEL; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR;

ADOLESCENT; ADULT; AUSTRALIA; CIRCUMCISION, MALE; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MODELS, THEORETICAL; YOUNG ADULT;

EID: 71949086904     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/648472     Document Type: Article

References (49)

1. National Centre in HIV Epidemiology and Clinical Research (NCHECR). HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia annual surveillance report. Sydney: NCHECR, 2008.
2. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2005; 2: e298.
3. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369:643-656
4. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369:657-666
5. Millett GA, Flores SA, Marks G, Reed JB, Herbst JH. Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA 2008; 300:1674-1684
6. Templeton DJ, Jin F, Mao L, et al. Reduced risk of HIV seroconversion among circumcised homosexual men who report a preference for the insertive role in anal intercourse. In: Program and abstracts of the 20th Australasian Society for HIV Medicine (ASHM) Conference (Perth). Darlinghurst, NSW: ASHM, 2008:98.
7. 7. Gray RH, Li X, Kigozi G, et al. The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS 2007; 21:845-850 (Pubitemid 46573156)
8. Kahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med 2006; 3:e517.
9. Fieno JV Costing adult male circumcision in high HIV prevalence, low circumcision rate countries. AIDS Care 2008; 20:515-520
10. Australian College of Paediatrics. Position statement: routine circumcision of normal male infants and boys. Parkville, Victoria: Australian College of Paediatrics, 1996.
11. 11. Prestage G, Ferris J, Grierson J, et al. Homosexual men in Australia: population, distribution and HIV prevalence. Sexual Health 2008; 5: 97-102. (Pubitemid 351786447)
12. Gold M, Seigel J, Russell L, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.
13. Organisation for Economic Co-operation and Development (OECD). Purchasing power parity 2008. Paris: OECD, 2008.
14. 14. Richters J, Smith AM, de Visser RO, Grulich AE, Rissel CE. Circumcision in Australia: prevalence and effects on sexual health. Int J STD AIDS 2006; 17:547-554 (Pubitemid 44285730)
15. O'Donnell H. Circumcision incidence in Australia. Circumcision Reference Library Web site.http://www.cirp.org/library/statistics/Australia/. Created Feburary 2004. Revised 10 September 2006. Accessed 23 No-vember 2008.
16. 16. Templeton DJ, Mao L, Prestage G, Kaldor JM, Kippax S, Grulich AE. Demographic predictors of circumcision status in a community-based sample of homosexual men in Sydney, Australia. Sex Health 2006; 3: 191-193 (Pubitemid 44325581)
17. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929
18. 18. Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. AIDS 2006; 20:731-739 (Pubitemid 43884301)
19. 19. Read TR, Hocking J, Sinnott V, Hellard M. Risk factors for incident HIV infection in men having sex with men: a case-control study. Sexual Health 2007; 4:35-39 (Pubitemid 46311107)
20. Mao L, Crawford JM, Hospers HJ, et al. "Serosorting" in casual anal sex of HIV-negative gay men is noteworthy and is increasing in Sydney, Australia. AIDS 2006; 20:1204-1206
21. 21. Crawford JM, Kippax SC, Mao L, et al. Number of risk acts by relationship status and partner serostatus: findings from the HIM cohort of homosexually active men in Sydney, Australia. AIDS Behav 2006; 10:325-331 (Pubitemid 43920279)
22. National Centre in HIV Epidemiology and Clinical Research. Gay Periodic Surveys, 1998-2006. University of New South Wales Web site. Available at http://nchsr.arts.unsw.edu.au/nchsr-library/search-results.php?spsrch = PeriodicSurveys&call = y. Accessed 23 November 2008.
23. Grierson J, Thorpe R, Pitts M. HIV futures 5: life as we know it. Australian Research Centre in Sex, Health and Society monograph series no. 60. Melbourne: Latrobe University, 2006.
24. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002:CD003255.
25. 25. Fitch JT, Stine C, Hager WD, Mann J, Adam MB, McIlhaney J. Condom effectiveness: factors that influence risk reduction. Sex Transm Dis 2002; 29:811-817 (Pubitemid 35425312)
26. 26. Van de Ven P, Mao L, Fogarty A, et al. Undetectable viral load is associated with sexual risk taking in HIV serodiscordant gay couples in Sydney. AIDS 2005; 19:179-184 (Pubitemid 40409536)
27. 27. Blower S, Bodine E, Kahn J, McFarland W The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. AIDS 2005; 19:1-14. (Pubitemid 40111013)
28. 28. Zhang H, Dornadula G, Beumont M, et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998; 339:1803-1809 (Pubitemid 29005784)
29. 29. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 2008;372:314-320 (Pubitemid 352020440)
30. Jin F, Crawford J, Prestage G, et al. Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS 2009; 23:243-252
31. Wilson DP. Modelling based on Australian HIV notifications data suggests homosexual age mixing is primarily assortative. J Acquir Immune Defic Syndr 2009; 51:356-360
32. 32. Mills E, Cooper C, Anema A, Guyatt G. Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11050 men. HIV Medicine 2008; 9: 332-335 (Pubitemid 352015640)
33. Rottingen JA, Garnett GP. The epidemiological and control implications of HIV transmission probabilities within partnerships. Sex Transm Dis 2002; 29:818-827
34. Kaplan EH. Modeling HIV infectivity: must sex acts be counted? J Acquir Immune Defic Syndr 1990; 3:55-61.
35. Wilson DP, Hoare A, Regan DG, Law MG. Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men. Sexual Health 2009; 6:19-33.
36. Australian Government Department of Health and Ageing. Public sector costs, 2006-2007. Canberra: Australian Government Department of Health and Ageing, 2008.
37. Medicare Australia. Medicare benefits schedule, 2008. Australian Government Department of Health and Ageing Web site. http://www. health.gov.au/internet/mbsonline/publishing.nsf/Content/Medicare -Benefits-Schedule-MBS-1. Accessed 23 November 2008.
38. Kigozi G, Gray RH, Wawer MJ, et al. The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda. PLoS Med2008;5:e116.
39. 39. Schackman BR, Gebo KA, Walensky RP, et al. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 2006; 44:990-997 (Pubitemid 44674030)
40. 40. Hornberger J, Holodniy M, Robertus K, Winnike M, Gibson E, Verhulst E. A systematic review of cost-utility analyses in HIV/AIDS: implications for public policy. Med Decis Making 2007; 27:789-821. (Pubitemid 350136010)
41. Applied Economics. Returns on investment in public health: an epidemiological and economic analysis. Canberra: Australian Government Department of Health and Ageing, 2003.
42. Ventegodt S. Sex and the quality of life in Denmark. Arch Sex Behav 1998; 27:295-307.
43. Fieno JV Costing adult male circumcision in high HIV prevalence, low circumcision rate countries. AIDS Care 2008; 20:515-520
44. 44. Bernard D, Kippax S, Baxter D. Effective partnership and adequate investment underpin a successful response: key factors in dealing with HIV increases. Sex Health 2008; 5:193-201. (Pubitemid 351786446)
45. 45. Kigozi G, Watya S, Polis CB, et al. The effect of male circumcision on sexual satisfaction and function, results from a randomized trial of male circumcision for human immunodeficiency virus prevention, Rakai, Uganda. BJU Int 2008; 101:65-70. (Pubitemid 350233575)
46. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369:657-666
47. Begley E, Jafa K, Voetsch A, Heffelfinger J, Sullivan P. Willingness of men who have sex with men in the US to be circumcised as adults to reduce risk of HIV infection [abstract 983]. In: Program and abstracts of the 14th Conference on Retroviruses and Opportunistic Infections (CROI) (Los Angeles). Alexandria, VA: CROI, 2007.
48. Wilson DP, Kwon A, Anderson JS, Law MG, Kaldor J. Return on investment 2: evaluating the cost-effectiveness of needle and syringe programs among injecting drug users in Australia. Sydney: National Centre in HIV Epidemiology and Clinical Research, 2009.
49. Merson M, Padian N, Coates TJ, et al. Combination HIV prevention. Lancet 2008; 372:1805-1806